Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)

被引：1
|
作者：
Autio, Karen A.
Anand, Aseem
Krupa, Rachel
Louw, Jessica
Arslan, Zaina
Dittamore, Ryan
Scher, Howard I.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Epic Sci Inc, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
    Lunger, Lukas
    Tauber, Robert
    Feuerecker, Benedikt
    Gschwend, Jurgen E.
    Eiber, Matthias
    Heck, Matthias M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 3963 - 3971
  • [32] Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Schonhoft, Joseph
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)
  • [33] CD133 expression in circulating tumor cells (CTCs) from metastatic castration-resistant prostate cancer (mCRPC).
    Ana Marcos, Rosa
    Alfonso, Sara
    Lozano, Rebeca
    Matos, Ignacio
    Espinet, Blanca
    Garcia, Rocio
    Maria Hernandez, Jesus
    Gomez-Veiga, Francisco
    Luis Hernandez, Juan
    Cruz, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer
    Theil, Gerit
    Schmidt, Stefanie
    Fischer, Kersten
    Lucke, Klaus
    Fornara, Paolo
    CANCER RESEARCH, 2016, 76
  • [35] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy
    Derlin, Thorsten
    Riethdorf, Sabine
    Schumacher, Udo
    Lafos, Marcel
    Peine, Sven
    Coith, Cornelia
    Ross, Tobias L.
    Pantel, Klaus
    Bengel, Frank M.
    PROSTATE, 2023, 83 (11): : 1076 - 1088
  • [37] Non-invasive assessment of prostate specific membrane antigen (PSMA) expression as a prognostic marker in men with metastatic castration resistant prostate cancer (mCRPC)
    Pinto-Chengot, Kavya
    Jhanwar, Yuliya
    Batra, Jaspreet
    Karir, Beerinder
    Vallabhajosula, Shankar
    Christos, Paul
    Molina, Ana
    Beltran, Himisha
    Nanus, David M.
    Goldsmith, Stanley J.
    Bander, Neil H.
    Tagawa, Scott T.
    CANCER RESEARCH, 2016, 76
  • [38] Our initial experience with Lu-177 PSMA (Pluvicto) for Metastatic prostate-specific membrane antigen-aε"-positive metastatic castration-resistant prostate cancer
    Cardenas, Karol
    Atcheson, Kyle
    Bradley, Yong
    Benayoun, Marc
    Cengiz, Turgut Bora
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [39] PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) RECEIVING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED RADIONUCLIDE THERAPY
    Stangl-Kremser, Judith
    Sun, Michael
    Ho, Benedict
    Thomas, Joseph
    Nauseef, Jones
    Osborne, Joseph
    Molina, Ana
    Sternberg, Cora
    Nanus, David
    Bander, Neil
    Tagawa, Scott
    JOURNAL OF UROLOGY, 2023, 209 : E384 - E385
  • [40] Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.
    Lorente, David
    Olmos, David
    Mateo, Joaquin
    Zafeiriou, Zafeiris
    Rescigno, Pasquale
    Bianchini, Diletta
    Mehra, Niven
    Molina, Arturo
    Kheoh, Thian
    Baeten, Kurt
    Mccormack, Robert Thomas
    Terstappen, Leon W. M. M.
    Scher, Howard I.
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345